Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis
- PMID: 16533137
- DOI: 10.1586/14737175.6.3.323
Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis
Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS, characterized by demyelination and neurodegeneration. Besides the sensory and motor deficits that are the hallmark of this disease, approximately 50% of MS patients are cognitively impaired. Over the years, structural neuroimaging has been used widely in MS patients for both diagnostic and research purposes. Various conventional and nonconventional magnetic resonance imaging (MRI) measures have provided important information about the degree and mechanisms of cerebral pathology, and these measures correlate with cognitive and affective disturbances. In this article, recent contributions to the literature regarding the correlation between MRI and neuropsychological function in MS are reviewed.
Similar articles
-
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.Neurology. 2008 Aug 26;71(9):632-8. doi: 10.1212/01.wnl.0000324621.58447.00. Neurology. 2008. PMID: 18725589
-
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.Neurology. 2009 Aug 18;73(7):498-503. doi: 10.1212/WNL.0b013e3181b351fd. Epub 2009 Jul 29. Neurology. 2009. PMID: 19641173
-
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544. Mult Scler. 2009. PMID: 19542262
-
[Cognitive impairment].Rev Neurol (Paris). 2009 Mar;165 Suppl 4:S113-22. doi: 10.1016/S0035-3787(09)72122-8. Rev Neurol (Paris). 2009. PMID: 19361675 Review. French.
-
The neuropsychiatry of multiple sclerosis: a review of recent developments.Curr Opin Psychiatry. 2007 May;20(3):278-85. doi: 10.1097/YCO.0b013e3280eb10d7. Curr Opin Psychiatry. 2007. PMID: 17415083 Review.
Cited by
-
Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.J Neurochem. 2014 Jul;130(2):268-79. doi: 10.1111/jnc.12659. Epub 2014 Feb 12. J Neurochem. 2014. PMID: 24447070 Free PMC article.
-
Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis.J Neurosci Res. 2010 Aug 15;88(11):2398-408. doi: 10.1002/jnr.22408. J Neurosci Res. 2010. PMID: 20623621 Free PMC article.
-
Kessler Foundation Strategy-Based Training to Enhance Memory (KF-STEM™): Study protocol for a single site double-blind randomized, clinical trial in Multiple Sclerosis.Contemp Clin Trials Commun. 2022 Nov 3;30:101026. doi: 10.1016/j.conctc.2022.101026. eCollection 2022 Dec. Contemp Clin Trials Commun. 2022. PMID: 36387993 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical